article thumbnail

Precigen Receives the US FDA’s IND Clearance of PRGN-2009 + Pembrolizumab for the Treatment of Recurrent or Metastatic Cervical Cancer

PharmaShots

Shots: The US FDA has cleared the IND application to initiate a P-II study evaluating PRGN-2009 (off-the-shelf AdenoVerse immunotherapy) + pembrolizumab vs pembrolizumab monotx. while the secondary objectives incl. while the secondary objectives incl.

40
article thumbnail

Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case

STAT

South San Francisco biotech Genentech on Thursday announced that an internal review of misconduct allegations concerning a landmark 2009 paper co-authored by Marc Tessier-Lavigne, a former top executive at the company and Stanford University’s current president, did not find any evidence of fraud or intentional wrongdoing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Do dementia villages actually work? We just don’t know

STAT

Originating in Weesp, Netherlands, in 2009 in a village known as the Hogeweyk, the concept created a paradigm shift in dementia care, focusing on possibilities instead of disabilities. ” Dementia villages are small-scale communities that offer shared housing, minor medical care, and psychosocial support in a neighborhood setting.

334
334
article thumbnail

STAT+: New mega-deal highlights Geisinger’s fall, and raises concerns about where Kaiser is going next

STAT

In 2009, when President Barack Obama was touring the country and ginning up support for what would eventually become the Affordable Care Act, Geisinger entered the mainstream.

Hospitals 257
article thumbnail

Opinion: New draft recommendations for mammograms take a one-size-fits-all approach

STAT

This is the USPSTF’s first substantial change to its breast cancer screening recommendations since 2009. In 2009 and 2016, in light of growing evidence of the harms of mammography screening and the limited benefits among average-risk individuals under 50, the USPSTF recommended screening every two years starting at 50.

201
201
article thumbnail

Opinion: Why new guidelines recommending screening at 40 can’t end the mammography wars

STAT

The agency now recommends beginning at age 40 , reversing the age-50 guideline that had been in place since 2009. New breast cancer screening guidelines from the United States Preventive Services Task Force give the impression that the decades-long debate over when women should start getting mammograms is settled.

239
239
article thumbnail

Opinion: Physician and Rep. Raul Ruiz: The infectious disease doctor shortage threatens future pandemic preparedness

STAT

In 2009, I was practicing in the emergency department when the H1N1 pandemic emerged. Then, I saw firsthand the vital role infectious disease physicians played in not only facilitating a coordinated public health response, but also helping patients, providers, and the public navigate the uncertainty that comes with confronting a novel virus.

Hospitals 355